1
SpinChem’s rotating bed reactor (RBR) technology is deployed in more than 40 countries. Strengthened by the new EU–India Free Trade Agreement, the company is now expanding its presence in India’s pharmaceutical markets through a partnership with Smart Labtech.
“India is a significant opportunity for SpinChem. The combination of rapid industry growth and an increasing need for scalable biocatalysis means our RBR technology is expanding at exactly the right time,” said Dr. Emil Byström, CEO of SpinChem.
India is the world’s third largest pharmaceutical producer by…